About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effects of Acleara Needle Insert on Acne | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01677221

Effects of Acleara Needle Insert on Acne

This prospective, open-label study will be conducted in 15 healthy subjects per clinical site ages 14 or older who meet the inclusion/exclusion criteria. Each subject may have up to 5 lesions treated ...

Lead sponsor: Theravant Corporation•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Theravant Corporation

Age

14 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Subjects \>14 years of age
•Subject has mild to moderate acne vulgaris on the face, chest or back.
•Subject has one or more inflammatory acne lesions on face, chest or back.
•Willingness to participate in the study
•Informed consent agreement signed by the subject
•Willingness to follow the treatment schedule and post treatment care requirements
•Willingness to remain on current acne therapy as directed by the Investigator.

Exclusion Criteria

•Subject has an infection or other dermatologic condition (aside from acne) in the area to be treated
•Subject is immunosuppressed
•Subject is unable to comply with treatment or follow-up visits
•Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.

Related studies

Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris

NCT07205107 · Acne Vulgaris

RECRUITINGEARLY Phase 1

Weekly Isotretinoin vs Tetracycline for Moderate Acne

NCT06225570 · Acne Vulgaris

RECRUITINGPhase 1/2

Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

NCT05891795 · Acne Vulgaris

RECRUITINGPhase 3

Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients

NCT06447480 · Acne Vulgaris

Vitamin D Supplementation in Acne

NCT06141330 · Acne Vulgaris

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 10, 2013Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment30

Start dateJul 2012

Last updatedJan 10, 2013

Condition

Locations shown

Charles County Dermatology Associates

White Plains, Maryland

Bellaire Dermatology Associates

Bellaire, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 10, 2013Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions